Despite the increased recognition of an association between YKL-40 and neurological disorders [1]–[6], it is not yet known how circulatory YKL-40 changes early after acute ischemic stroke (AIS) onset or whether it is a feasible biomarker for AIS in clinical practice. Here, CHI3L1 is linked to androgen insensitivity syndrome.